Stephen Pandol to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Stephen Pandol has written about Xenograft Model Antitumor Assays.
Connection Strength
0.049
-
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. Oncotarget. 2016 Mar 29; 7(13):17103-10.
Score: 0.030
-
Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol. 2010 Jan; 298(1):G63-73.
Score: 0.019